Patents by Inventor Christopher Turchik Jagoe

Christopher Turchik Jagoe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for treating cells resistant to antineoplastic agents
    Patent number: 6774143
    Abstract: The present invention relates to methods for treating multidrug resistant cells, preferably multidrug resistant cancer cells with discodermolide. Discodermolide is found to be effective in limiting the growth of otherwise growth unregulated cells having tubulin mutations and in promoting phosphorylation of the oncogene RAF-1.
    Type: Grant
    Filed: April 10, 2003
    Date of Patent: August 10, 2004
    Assignee: Novartis AG
    Inventors: Peter Lassota, Christopher Turchik Jagoe
  • Use of certain substituted caprolactams in treating tumors
    Patent number: 6555533
    Abstract: The present invention relates to certain substituted caprolactam compounds, pharmaceutical compositions containing said compounds, the use of said compounds in treating tumors and to a process for making said compounds.
    Type: Grant
    Filed: March 12, 2001
    Date of Patent: April 29, 2003
    Assignee: Novartis AG
    Inventors: Frederick Ray Kinder, Jr., Kenneth Walter Bair, Christopher Turchik Jagoe, Richard William Versace, Sompong Wattanasin
  • Use of certain substituted caprolactams in treating tumors
    Publication number: 20010044433
    Abstract: The present invention relates to certain substituted caprolactam compounds, pharmaceutical compositions containing said compounds, the use of said compounds in treating tumors and to a process for making said compounds.
    Type: Application
    Filed: March 12, 2001
    Publication date: November 22, 2001
    Inventors: Frederick Ray Kinder, Kenneth Walter Bair, Christopher Turchik Jagoe, Richard William Versace, Sompong Wattanasin
  • Certain substituted caprolactams, pharmaceutical compositions containing them and a process for their preparation
    Patent number: 6239127
    Abstract: The present invention relates to certain substituted caprolactam compounds of formula (I), where R1 is (C1-6)alkyl or (C3-6)cycloalkyl; R2 hydrogen or (C1-6)alkyl; X is (C1-12)alkynylene; (C2-12)alkynylene; m is 0 or 1; and R3 is (C3-8)cycloalkyl; or an aromatic ring system selected from (II, III, IV and V), where R4 is hydrogen, chloro, or methoxy; R5 is hydrogen, chloro, (C1-18)alkyl or (C1-18)alkoxy, and Z is oxygen, sulfur, N—H, or N—CH3; or a pharmaceutically acceptable acid addition salt thereof, where possible, pharmaceutical compositions containing said compounds, the use of said compounds in treating tumors and to a process for making said compounds.
    Type: Grant
    Filed: November 17, 1999
    Date of Patent: May 29, 2001
    Assignee: Novartis AG
    Inventors: Frederick Ray Kinder, Jr., Kenneth Walter Bair, Christopher Turchik Jagoe, Richard William Versace, Sompong Wattanasin